Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

2 terminated/withdrawn out of 6 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
4(66.7%)
Phase 1
1(16.7%)
Phase 2
1(16.7%)
6Total
N/A(4)
Phase 1(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07027735Not ApplicableRecruiting

Decellularized Human Placental Extracellular Matrix Tissue for Rotator Cuff Repair Augmentation

Role: collaborator

NCT06712290Not ApplicableWithdrawn

Connective Tissue Matrix Compared to Steroid Injections for Rotator Cuff Tendinopathy

Role: collaborator

NCT06171529Not ApplicableUnknown

Efficacy of a Single Injection of CTM for Post-Operative CMC Arthritis

Role: collaborator

NCT06171542Phase 1Unknown

Efficacy of a Single Image Guided Injection of CTM for Glenohumeral Arthritis

Role: collaborator

NCT06171555Phase 2Unknown

Efficacy of CTM for Tennis ELbow

Role: collaborator

NCT04633837Not ApplicableTerminated

Examining the Effectiveness of a Connective Tissue Matrix Implant in Reducing Post-operative Pain and Narcotic After Outpatient Arthroscopic Shoulder Surgery

Role: collaborator

All 6 trials loaded